Skip to main content

Table 2 In-hospital non-fatal complications and mortality-risk assessment

From: Medium and long-term follow-up after ST-segment elevation myocardial infarction in a sub-Saharan Africa population: a prospective cohort study

Complications

Total N = 282

Revascularization n = 94

No revascularization n = 166

P

Arrythmias

76 (27.0)

30 (30.7)

46 (25.0)

0.31

Conduction disturmbances

44 (15.6)

13 (13.3)

31 (16.8)

0.62

Heart failure

72 (25.5)

18 (18.4)

54 (29.3)

0.04

Cardiogenic shock

13 (4.6)

4 (4.1)

9 (4.9)

0.99

Extension of MI

28 (9.9)

5 (5.1)

23 (12.5)

0.04

Thromboembolism

17 (6.0)

6 (6.1)

11 (6.0)

0.96

GRACE Score, m [IQR]

107 [86–126]

94 [85–120]

108 [88.5–127.0]

0.16

6 months MRA(%), m [IQR]

4.4 [2.6–7.9]

3.5 [1.6–6.2]

5.3 [2.6–8.8]

0.02

One-year MRA(%), m [IQR]

5.3 [2.7–11.0]

3.5 [2.1–6.9]

5.3 [2.9–11.0]

0.04

Three-years MRA(%), m [IQR]

11.0 [5.5–20.0]

8.6 [4.8–11.0]

11.5 [5.7–21.0]

0.04

  1. Data are in n(%). m [IQR]: median [interquartiles range]
  2. MI Myocardial Infarction, MRA mortality risk assessment by GRACE Score